centstability4me, I have read up on the RTT act announced by Trump that terminally ill cancer patients can opt for drugs that not have necessarily received approval from FDA but can be used provided it is recommended by the Doctors Community and also INsurance community.
Considering TSOI has initiated trial on cancer patients for adjuvant drug. longs are waiting for the results to be published in the medical journal. If that happens what is your take on PPS target for TSOI? thanks
News 
Market Data 
Discover 
AI
